oa Right atrial thrombus in cholangiocellular carcinoma: Case report and a review of the literature

References

1. Hammill CW, Wong LL. Intrahepatic cholangiocarcinoma: a malignancy of increasing importance. J Am Coll Surg. 2008 207::594–603
   [Google Scholar]
2. Tasi SH, Juan CJ, Dai MS, Kao WY. Trousseau's syndrome related to adenocarcinoma of the colon and cholangiocarcinoma. Eur J Neurol. 2004 Jul 11:7:493–496
   [Google Scholar]
3. Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, Olsen JH, McGlynn KA. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer. 2007 120:3:638–641
   [Google Scholar]
4. Martin RC, Klimstra DS, Schwartz L, Yilmaz A, Blumgart LH, Jarnagin W. Hepatic intraductal oncocytic papillary carcinoma. Cancer. 2002 95:10:2180–2187
   [Google Scholar]
5. Tabata M, Kawarada Y, Yokoi H, Higashiguchi T, Isaji S. Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2000 7:2:148–154
   [Google Scholar]
6. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002 95:8:1685–1695
   [Google Scholar]
7. Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med. 2007 May 3 356:18:1862–1869
   [Google Scholar]
8. Chan SL, Arifi AA, Chan AB, Chan AT, Ma BB. An unusual cause of superior vena cava obstruction. Thorax. 2006 Feb 61:2:182
   [Google Scholar]
9. Trousseau A. Plegmasia alba dolens. Lectures on clinical medicine, delivered at the Hotel-Dieu, Paris. 1865 5::281–332
   [Google Scholar]
10. Rickles FR. Mechanisms of cancer-induced thrombosis in cancer. Pathophysiol Haemost Thromb. 2006 35::103–110
    [Google Scholar]
11. Lee AY. Cancer and thromboembolic disease: pathogenic mechanisms. Cancer Treat Rev. 2002 28::137–140
    [Google Scholar]
12. Taniai M, Grambihler A, Higuchi H, Werneburg N, Bronk SF, Farrugia DJ, Kaufmann SH, Gores GJ. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res. 2004 May 15 64:10:3517–3524
    [Google Scholar]
13. Grignani G, Falanga A, Pacchiarini L, Alessio MG, Zucchella M, Fratino P, Donati MB. Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties. Int J Cancer. 1988 Oct 15 42:4:554–557
    [Google Scholar]
14. Donati MB, Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol. 2001 106:1–2:18–24
    [Google Scholar]
15. Ross R, Vogel A. The platelet-derived growth factor. Cell. 1978 14:2:203–210
    [Google Scholar]
16. Ohi M, Miki C. Tissue concentration of platelet-derived endothelial cell growth factor in colorectal cancer. Scand J Gastroenterol. 2000 35:4:413–418
    [Google Scholar]
17. Verheul HMW, Jorna AS, Hoekman K, Broxterman HJ, Gebbink MF, Pinedo HM. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood. 2000 96:13:4216–4221
    [Google Scholar]
18. Uenishi T, Hirohashi K, Haba T, Wakasa K, Kubo S, Shuto T, Tanaka H, Yamamoto T, Tanaka S, Kinoshita H. Portal thrombosis due to intrahepatic cholangiocarcinoma following successful treatment for hepatocellular carcinoma. Hepatogastroenterology. 2003 Jul-Aug 50:52:1140–1142
    [Google Scholar]
19. Kwon OS, Jun DW, Kim SH, Chung MY, Kim NI, Song MH, Lee HH, Kim SH, Jo YJ, Park YS, Joo JE. Distant skeletal muscle metastasis from intrahepatic cholangiocarcinoma presenting as Budd-Chiari syndrome. World J Gastroenterol. 2007 Jun 14 13:22:3141–3143
    [Google Scholar]
20. Vysetti S, Shinde S, Chaudhry S, Subramoney K. Phlegmasia cerulea dolens—a rare, life-threatening condition. Scientific World J. 2009 Oct 14 9::1105–1106
    [Google Scholar]
21. Galvez JA, Clebone A, Garwood S, Popescu WM. Fatal intraoperative cardiac thrombosis in a patient with renal cell carcinoma. Anesthesiology. 2011 May 114:5:1212
    [Google Scholar]
22. Chen H, Ng V, Kane CJ, Russell IA. The role of transesophageal echocardiography in rapid diagnosis and treatment of migratory tumor embolus. Anesth Analg. 2004 Aug 99:2:357–359
    [Google Scholar]
23. Woodruff DY, Van Veldhuizen P, Muehlebach G, Johnson P, Williamson T, Holzbeierlein JM. The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol. 2011 Apr 20. [Epub ahead of Print]
    [Google Scholar]
24. Giuliani ME, Knox J, Dawson LA. Malignant intracardiac thrombus from hepatocellular carcinoma treated with external beam radiation therapy. J Palliat Med. 2010 Oct 13:10:1293–1295
    [Google Scholar]
25. Costache VS, Lantuejoul S, Stoica S, Fluttaz A, Hacini R, Brichon PY. Giant intracardiac neoplasic thrombus of a large cell neuroendocrine carcinoma of the lung. Cardiovasc Pathol. 2010 May–Jun 19:3:e85–e87. Epub 2009 Jan 14
    [Google Scholar]
26. Shudo Y, Matsumiya G, Sakaguchi T, Fujita T, Yamauchi T, Sawa Y. Resection of advanced stage malignant retroperitoneal neoplasms with tumor thrombus extending into the right atrium: report of four cases. Surg Today. 2011 Feb 41:2:262–265
    [Google Scholar]
27. Gadducci A, Baicchi U, Marrai R, Facchini V, del Bravo B, Fosella PV, Fioretti P. Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand Factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol. 1993 49:3:354–358
    [Google Scholar]
28. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW, American Society of Clinical Oncology, American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007 25:34:5490
    [Google Scholar]
29. Kakkar AK. Antithrombotic therapy and survival in cancer patients. Best Pract Res Clin Haematol. 2009 22:1:147–151
    [Google Scholar]